Generic and disease-adapted cardiovascular risk scores as predictors of atherosclerosis progression in SLE.
Stylianos PanopoulosGeorge C DrososGeorge KonstantonisPetros P SfikakisMaria G G TektonidouPublished in: Lupus science & medicine (2023)
Application of SLE-adapted CVR scores such as QRISK3 or mFRS, as well as monitoring for glucocorticoid exposure and the presence of antiphospholipid antibodies, can help to improve CVR assessment and management in SLE.